Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02320825 · ClinicalTrials.gov registry record · Phase 3
Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 16
- Enrollment target
NCT02320825: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02320825 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02320825, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether giving one higher dose of radiation is as good at treating the tumor in the patient's spine after surgery as giving three lower doses of radiation.
Interventions
- RADIATION single-fraction SRS
- RADIATION high-dose hypofractionated SRS
- BEHAVIORAL Quality of Life Measures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-12-16 |
| Est. Completion | 2018-07-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02320825
The ClinicalTrials.gov registry entry for NCT02320825 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which single-fraction SRS is the first listed.
NCT02320825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02320825 about?
NCT02320825 is a clinical study titled "Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases". The purpose of this study is to find out whether giving one higher dose of radiation is as good at treating the tumor in the patient's spine after surgery as giving three lower doses of radiation.
What is the current status of trial NCT02320825?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 16 participants. The study started on 2014-12-16. Estimated completion is 2018-07-26.
What interventions are being tested in trial NCT02320825?
The interventions under investigation include: single-fraction SRS (RADIATION), high-dose hypofractionated SRS (RADIATION), Quality of Life Measures (BEHAVIORAL).
Who is sponsoring clinical trial NCT02320825?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.